The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework
This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Will the recent purchase of Kyphon by Medtronic signals the end of kyphoplasty? No because arcuoplasty does not restore vertebral height. Vertebroplasty, kyphoplasty and arcuoplasty essentially achieve the same goals, which brings up the question, do we need all three techniques? Arcuoplasty is the...
People, in general, who may have other concerns than their health, consume soft drinks, both regular and diet. High fructose corn syrup in our society is like lead to the Romans. Why is taking our government so long to figure this out?
Dapagliflozin has a long way to go to prove its efficacy and safety as a potential diabetes medication. However, innovative medications are welcome as they will be pieces of the diabetic solution puzzle.
Galvus does not seem to have a competitive edge over Januvia, its main competition. Galvus needs to demonstrate a yet unknown significant advantage to gain significant market share.
Long-term comparisons of glycemic control are lacking between newer and older diabetes medications. However this is a one-dimensional comparison. Newer medications have significant other advantages over the older medications, but both are needed to safely reach glycemic goals.
The porridge of attention being lavished upon anything related to augmentation of quality and outcomes in medical practice is becoming counterproductive and is obscuring important "currents" of information. To summarize EHR's as offering no benefit is akin to saying that the iphone given to John F Kennedy's...
Alzheimer's drug patch could change quality of life of the patient and their family. Usually patients with Alzheimer's disease have more than one disease and takes three up to fifteen different medications a day. Long span release patches are very convenient to this patients for many reasons, not only...
Symlin requires a significant burden on patients without much benefit. For the lucky few that can get away with basal insulin and Symlin and don’t mind the shots, it may be of some benefit.